Sijin Cheng
- Immunology top 5%
- Immune cells in cancer 6
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 7
- Inflammatory Biomarkers in Disease Prognosis 4
- Pancreatic and Hepatic Oncology Research 2
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism 3
-
- Single-cell and spatial transcriptomics 6
- Epigenetics and DNA Methylation 2
- RNA modifications and cancer 2
- Co-authors
- Zemin ZhangRanran GaoXianwen RenXueda HuLei ZhangLiang JiangXiliang WangBin Zhang
- Cited by
- ImmunologyOncologyCancer Research
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Sijin Cheng
27 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 94
- Immunology 736
- Oncology 732
- Cancer Research 363
- Molecular Biology 660
- Pulmonary and Respiratory Medicine 209
Countries citing papers authored by Sijin Cheng
This map shows the geographic impact of Sijin Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sijin Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sijin Cheng more than expected).
Fields of papers citing papers by Sijin Cheng
This network shows the impact of papers produced by Sijin Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sijin Cheng. The network helps show where Sijin Cheng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sijin Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 3 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 27 | |
| 7 | 2022 | 14 | |
| 8 | A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cellsbreakdown → | 2021 | 820 |
| 9 | 2021 | 108 | |
| 10 | 2021 | 30 | |
| 11 | 2019 | 97 | |
| 12 | 2018 | 4 | |
| 13 | 2018 | 66 | |
| 14 | 2018 | 50 | |
| 15 | 2018 | 113 | |
| 16 | 2018 | 14 | |
| 17 | 2018 | 22 | |
| 18 | 2018 | 14 | |
| 19 | 2018 | 34 | |
| 20 | 2016 | 34 |
About Sijin Cheng
Sijin Cheng is a scholar working on Cancer Research, Oncology and Immunology, having authored 29 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (7 papers), Single-cell and spatial transcriptomics (6 papers), Immune cells in cancer (6 papers), Inflammatory Biomarkers in Disease Prognosis (4 papers), Cancer, Lipids, and Metabolism (3 papers), Epigenetics and DNA Methylation (2 papers), Pancreatic and Hepatic Oncology Research (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Immunology (736 citations), Oncology (732 citations) and Cancer Research (363 citations). Sijin Cheng has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Zemin Zhang, Ranran Gao, Xianwen Ren, Xueda Hu, Lei Zhang, Liang Jiang, Xiliang Wang, Bin Zhang, Zhaode Bu and Yunong Gao. Their work appears in journals such as Cell, Nucleic Acids Research and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.